In vitro inhibition of STAT5 signaling limits CD8⁺ T cell exhaustion and improves outcomes in adoptive T-cell therapy

Cancer Immunology Research · Published 2026-07-22 · DOI 10.1158/2326-6066.cir-25-1493

Free full text

Authors (13)

Mitra Shourian, Benoîte Bourdin, Nehme El-Hachem, Clémence Ruisseaux, Alexis Vallée, Arnau Ballestero Vidal, Olivier Gingras, Hugo Roméro, Edward O. Kwarteng, Élie Haddad, Vincent-Philippe Lavallée, Jean-Christophe Beltra, Hélène Decaluwe

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Shourian, M., Bourdin, B., El-Hachem, N., et al. (2026). In vitro inhibition of STAT5 signaling limits CD8⁺ T cell exhaustion and improves outcomes in adoptive T-cell therapy. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-25-1493

Related articles